Anti-cetuximab IgE ELISA for identification of patients at a high risk of cetuximab-induced anaphylaxis

Cetuximab, a chimeric mouse-human IgG1 monoclonal antibody against the epidermal growth factor receptor, has proven effective in the treatment of metastatic colorectal cancer and squamous cell carcinoma of the head and neck. However, a high incidence of immediate hypersensitivity reactions (HSR) to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mariotte, Delphine, Dupont, Benoît, Gervais, Radj, Galais, Marie-Pierre, Laroche, Dominique, Tranchant, Aurore, Comby, Elisabeth, Bouhier-Leporrier, Karine, Reimund, Jean-Marie, Le Mauff, Brigitte
Formato: Artigo
Idioma:Inglês
Publicado em: Landes Bioscience 2011
Assuntos:
Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3218536/
https://ncbi.nlm.nih.gov/pubmed/21654207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/mabs.3.4.16293
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados